Brii Biosciences Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	-	-	0.62	51.63	-	-
Other Revenue	28.77	49.94	55.27	70.65	92.54	82.22
Revenue	28.77	49.94	55.89	122.28	92.54	82.22
Revenue Growth (YoY)	-24.18%	-10.66%	-54.29%	32.13%	12.56%	307.10%
Gross Profit	28.77	49.94	55.89	122.28	92.54	82.22
Selling, General & Admin	132.75	153.16	197.92	195.49	208.4	103.4
Research & Development	240.7	249.85	402.71	440.63	494.62	875.8
Operating Expenses	391.28	453.79	600.62	636.12	703.02	979.19
Operating Income	-362.51	-403.85	-544.73	-513.85	-610.48	-896.97
Interest Expense	-3.28	-2.37	-0.49	-0.85	-1.18	-1.67
Interest & Investment Income	65.56	87.15	108.02	37.2	6.49	2.41
Currency Exchange Gain (Loss)	-2.35	1.67	121.59	-43.98	0.27	-6.97
Other Non Operating Income (Expenses)	5.06	5.06	0.43	-	-	-
EBT Excluding Unusual Items	-297.52	-312.34	-315.18	-521.47	-604.9	-903.21
Gain (Loss) on Sale of Investments	10.59	-109.69	136.24	31.69	44.8	-15.02
Asset Writedown	-91.07	-90.35	-5.43	-	-	-
Other Unusual Items	-	-	-	-	-3,631	-365.28
Pretax Income	-377.99	-512.38	-184.37	-489.78	-4,191	-1,284
Earnings From Continuing Operations	-377.99	-512.38	-184.37	-489.78	-4,191	-1,284
Minority Interest in Earnings	2.3	4.22	9.54	5.47	27.24	93.91
Net Income	-375.69	-508.16	-174.83	-484.31	-4,164	-1,190
Net Income to Common	-375.69	-508.16	-174.83	-484.31	-4,164	-1,190
Shares Outstanding (Basic)	727	730	728	723	439	191
Shares Outstanding (Diluted)	727	730	728	723	439	191
Shares Change (YoY)	-0.28%	0.29%	0.64%	64.78%	129.57%	7.08%
EPS (Basic)	-0.52	-0.70	-0.24	-0.67	-9.48	-6.22
EPS (Diluted)	-0.52	-0.70	-0.24	-0.67	-9.48	-6.22
Free Cash Flow	-370.97	-376.12	-594.01	-496.28	-880.49	-403.72
Free Cash Flow Per Share	-0.51	-0.52	-0.82	-0.69	-2.00	-2.11
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-1259.84%	-808.74%	-974.63%	-420.22%	-659.68%	-1090.97%
Profit Margin	-1305.67%	-1017.63%	-312.80%	-396.07%	-4499.41%	-1446.88%
Free Cash Flow Margin	-1289.25%	-753.20%	-1062.81%	-405.86%	-951.45%	-491.03%
EBITDA	-362.24	-401.61	-538.15	-505.9	-602.8	-890.79
D&A For EBITDA	0.27	2.25	6.59	7.94	7.68	6.19
EBIT	-362.51	-403.85	-544.73	-513.85	-610.48	-896.97

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.